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OBJECTIVES The objective of this study was to determine whether a small-size valve prosthesis contributes
to exercise intolerance, as assessed by VO2 measurement during an exhaustive cycle ergometer
exercise.
BACKGROUND The determinants of exercise capacity after mechanical aortic replacement are not well known.
The selection of small valve sizes has, however, been described as an independent predictor
of exercise intolerance as assessed by exercise duration. Maximal oxygen uptake (VO2 max) is
a good index of exercise tolerance.
METHODS Fourteen patients were eligible, with a mean age of 62 6 6 years. Before surgery, the mean
left ventricular ejection fraction (LVEF) was 73 6 8%. Two valve types with small diameter
(19 to 21 mm) were used: Medtronic Hall and St Jude Medical. A healthy sedentary control
group (n 5 14) paired for age, weight and size was constituted. After one year of follow-up,
cardiorespiratory tests were performed. In addition, the gradients through the prostheses were
determined by continuous pulse Doppler at rest and immediately after the cardiorespiratory
test.
RESULTS The exercise tolerance was not significantly different between the control group and patient
group: VO2 peak (21.7 vs. 20.4 ml/kg/min; p 5 0.42), workloads (115 vs. 93 W; p 5 0.13)
and ventilatory parameters were similar. The mean and peak gradients at rest and during
exercise were not correlated with VO2max.
CONCLUSIONS Valve replacement by small aortic prosthesis does not seem to be a factor of exercise
intolerance as assessed by VO2 max in patients without LVEF dysfunction before surgery. (J
Am Coll Cardiol 2000;36:871–7) © 2000 by the American College of Cardiology
In the case of a small aortic annulus, the choice of prosthesis
size is very important. If a medium-size prosthesis is
selected, the consequences include prolonged surgical pro-
cedure and increased operative risk (1) due to surgical root
enlargement. A small size, however, may increase the risk of
residual outflow obstruction (2). Moreover, small prosthesis
size has been reported to be an independent factor in sudden
death, particularly when the body surface area and prosthe-
sis size are mismatched (3). Nevertheless, in current surgical
practice, a small prosthesis is most frequently used in this
indication.
A negative influence of small prosthesis size on exercise
capacity has been suggested. This is thought to be due
mainly to high transaortic gradients during exercise that are
not observed at rest and also to other factors such as a
smaller left ventricular cavity (4). After aortic valve replace-
ment, the patient’s functional level usually improves, but the
effective prosthetic valve area is smaller than that of healthy
native valves. Few studies have described the exercise
tolerance after valve implantation. Indeed, the determinants
of exercise capacity after mechanical aortic replacement are
not well known. Tatineni et al. (5) showed that, as expressed
by exercise duration, prosthesis size is an independent
predictor of exercise tolerance.
Maximal oxygen uptake (VO2max) is a good index of
exercise capacity and is used for prognosis in cardiac disease
(6). To our knowledge, the evaluation of exercise capacity as
assessed by VO2max, compared with that of control subjects,
has not been studied in patients with small aortic prosthesis
(#21 mm). Hirooka et al. (7) compared the percentage of
predicted peak oxygen consumption in relationship to four
valve sizes (19 to 25 mm) without statistically significant
results. In their study, predicted peak oxygen consumption
tended to be lower, however, in patients with a prosthesis
size of 19 mm than in those with a size of 25 mm. This
suggests that patients with small aortic prostheses present an
exercise intolerance. The mechanisms may involve a residual
outflow obstruction at rest that is increased during exercise
(2); however, we do not know whether hemodynamic
characteristics of these small prostheses were a determinant
of exercise tolerance. Hemodynamic evaluation of prosthesis
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function by Doppler echocardiography is frequently per-
formed at rest (8) and less often during exercise (9). Several
studies have found strong correlations between the pressure
gradient across the prosthetic valve at rest and during
exercise (4,5,9).
Consequently, we do not know whether patients with a
small aortic valve prosthesis have a real exercise limitation,
or if hemodynamic characteristics have a role in this
limitation. The aims of this study were 1) to determine
exercise tolerance, by VO2max measurement during exhaus-
tive exercise, in patients after aortic valve replacement with
small-size prostheses (#21 mm) compared to a paired
control group without prosthesis, and 2) to establish
whether this capacity is correlated with hemodynamic data
collected at rest and during exercise. In addition, we
compared the hemodynamic and exercise tolerance capacity
characteristics of patients with two types of small mechan-
ical prosthesis in aortic location: St. Jude Medical (SJM)
and Medtronic Hall (MH).
METHODS
Patients. From March 1993 to September 1994, a total of
14 small aortic valve prostheses (#21 mm) were implanted.
Two types of valve were used: Medtronic Hall (no. 21, n 5
6) and St. Jude Medical (no. 19, n 5 7; no. 21, n 5 1). After
surgery, the patients were prospectively studied with a mean
follow-up of 28 6 6 months. The mean age of patients was
62.4 6 6 years, with nine women and five men.
Before surgery, 13 patients had aortic stenosis; one had a
predominant insufficiency. All were free of significant cor-
onary artery disease: mean left ventricular ejection fraction
(LVEF) was 73 6 8% (using digital substraction angiogra-
phy), and the mean stenotic aortic gradient was 71 6
25 mm Hg. All patients were in sinus rhythm before and
after surgery and without exercise contraindication.
Control group. The healthy control group, matched for
gender, height and weight, was constituted at the same
period. It was composed of 14 normal sedentary subjects
without history of cardiovascular or pulmonary disease
based on the results of clinical, echocardiographic, electro-
cardiographic (ECG), and spirographic examination. All
subjects gave signed consent to participate in the study after
the design and risks of protocol were explained to them.
The study was also approved by the hospital ethics com-
mittee.
Spirographic measurements. Conventional spirographic
measurements were performed on a digital spirometer
(Pulmonet III, SensorMedics, Yorba Linda, California).
The lung function study included force expiratory volume in
1 s (FEV1) and vital capacity (VC). The FEV1/VC ratio
was then calculated. The predicted values were those of
Quanjer (10).
Doppler echocardiography. A complete echocardio-
graphic and Doppler examination was performed at rest in
the sitting position with SONOS 1500 Hewlett Packard
using a 2.5 duplex mechanical transducer. The usual data
were collected using M-mode, two-dimensional and
continuous-wave Doppler.
Maximal velocities across the prosthesis were measured
by continuous-wave Doppler from the apical view. Indeed,
the high-velocity jets were best recorded from the cardiac
apex, correlated with cardiac catheterization findings (11).
From the highest velocities obtained, the transprosthetic
pressure drop was calculated according to the Bernoulli
equation (12). Mean gradients were obtained by integrating
the Doppler velocity signals (13). The effective prosthesis
area was calculated with the continuity equation, using the
pulsed Doppler (13,14). Doppler measurements were per-
formed at rest and early after peak exercise, during the first
minute of recovery, using the same location of the Doppler
sampler, in the sitting position.
Cardiorespiratory exercise testing. Exercise tests were
performed on an electrically braked cycle ergometer with
heart rate, blood pressure and ECG monitoring under the
supervision of a physician. The subjects breathed through a
low-resistance valve (2700 Hans Rudolf, Kansas City,
Kansas) with the nose clamped. Expired flow and oxygen
and carbon dioxide partial pressures were continuously
monitored on a breath-by-breath basis using a cardiopul-
monary exercise test (CPX Medical Graphics System, Med-
ical Graphics, St. Paul, Minnesota). Ventilation (VE, liter/
min BTPS), O2 uptake (VO2 ml/min and ml/kg/min
STPD), and CO2 production (VCO2, liter/min STPD) were
calculated by averaging the breath-by-breath data over 30 s.
We also determined the respiratory gas exchange ratio (R 5
VCO2/VO2) and the ventilatory equivalents for O2 (VE/VO2)
and CO2 (VE/VCO2). The ventilatory threshold (Vt) was
determined as the level of VO2 at which an increase in
VE/VO2 was observed without a simultaneous change in
VE/VCO2 (15). The maximal minute ventilation at peak
exercise (VEmax) values were predicted by VEmax 5
measured FEV1 3 35 (16). The ventilatory reserve (VR) at
maximal exercise was calculated as follows: (100 2 [100 3
measured VEmax/predicted VEmax]) (17).
The exercise test consisted of a 3-min rest period,
followed by the maximal exercise test, which started with a
3-min warmup at 20 W with a minimum constant pedalling
Abbreviations and Acronyms
FEV1 5 forced expiratory volume in 1 s
HR 5 heart rate
LVEF 5 left ventricular ejection fraction
MH 5 Medtronic Hall
R 5 respiratory gas exchange ratio (VCO2/VO2)
SJM 5 St Jude Medical
VC 5 vital capacity
VEmax 5 minute ventilation at peak exercise
VO2max 5 maximal oxygen uptake
VO2 peak 5 peak oxygen consumption
VR 5 ventilatory reserve
Vt 5 ventilatory threshold
Wmax 5 maximal workload
872 Becassis et al. JACC Vol. 36, No. 3, 2000
Aortic Valve Replacement September 2000:871–7
rate of 60 rpm. For the patients, the workload was then
increased by 10 W every minute. For the healthy control
subjects, the workload increment (20 or 30 W) was chosen
to obtain an exercise duration between 8 and 12 min, which
is the optimal range for obtaining the highest values of peak
VO2 (18). Subjects were asked to continue exercise until
exhaustion (VO2 peak). The criteria for prematurely stop-
ping the test were defined as follows: serious cardiac
arrhythmia, fall in blood pressure, ECG changes compared
to resting value, and chest pain.
For every subject, the observation of at least three of the
four following criteria was necessary to consider that VO2
peak was obtained: stability of heart rate (HR) at a value
close to the predicted maximal HR; stability of oxygen
uptake despite the increase in workload; respiratory ratio
.1.10; and the inability of the subject to maintain a
pedalling rate of 50 rpm (17).
Protocol. The study protocol included spirometric values
at rest and maximal cardiopulmonary exercise testing for
both groups. The echocardiography Doppler measurements
at rest and early after peak exercise, during the first minute
of recovery, were performed for the aortic prosthesis group
using the same location of Doppler sample, in the sitting
position and by the same physician.
Statistical analysis. All data are expressed as mean 6
standard deviation (SD). The Student t test for unpaired
observations was used for between-group comparison when
the normality distribution (Kolmogorov-Smirnov test) and
the equality of variance (Levene median test) were verified.
When these conditions of normality were not obtained, a
Mann-Whitney rank sum test was used. The relationships
between the gas exchange and hemodynamic data were
assessed using linear regression analysis. A p value ,0.05
was considered statistically significant.
RESULTS
Anthropometric and spirometric characteristics. As
shown in Table 1, the anthropometric parameters did not
differ significantly between the two groups. The spirometric
data (Table 2) showed that FEV1 and VC were significantly
lower in patients than in controls; the FEV1/VC ratio was
not significantly different.
Exercise testing. The results of maximal exercise testing
are summarized in Table 3. Exercise capacity, expressed as
VO2 peak or %predicted VO2max, was not significantly
different between the two groups (Fig. 1). Similarly, no
difference was observed in the ventilatory parameters (VE,
VR and the ventilatory equivalents for VO2 and VCO2).
Patients with the SJM prosthesis had an exercise tolerance
comparable to those with MH. However, the maximal heart
rate expressed as a percentage of predicted value (% pre-
dicted HRmax) was lower in the patient group than in
controls (82 6 11 vs. 91 6 9 beats/min; p 5 0.03). The
maximal R (Rmax) was higher (p 5 0.03) in the controls,
but a mean value above 1.1 was observed in both groups. No
event occurred in either group to lead to an interruption of
exercise testing.
Doppler hemodynamic evaluations in the prosthetic
group: Rest and exercise data analysis. At rest, the mean
and peak transaortic gradients were, respectively, 21 6 8
and 35 6 13 mm Hg. With exercise, these gradients
increased in all patients: the mean gradient increased to
33 6 14 and the peak to 57 6 24 mm Hg; the acceleration
time of flow velocity increased to 3.01 6 0.54 to 3.59 6
0.78 (p 5 0.03). We did not observe a significant difference
for mean (p 5 0.70) or peak exercise (p 5 0.75) gradients
(Fig. 2) in the subgroups of patients with the 19-mm
prosthesis versus the 21-mm prosthesis. These exercise
gradients also did not differ (Fig. 3) for SJM versus MH:
(p 5 0.82 for mean exercise gradients; p 5 0.74 for peak
exercise gradients). A significant correlation between the
Table 1. Anthropometric Values of Control Group and Patients
Control Group Patients p Value
Age (yrs) 63 6 6 62 6 6 0.76 NS
Weight (kg) 68 6 11 69 6 11 0.88 NS
Height (cm) 164 6 10 160 6 8 0.30 NS
BMI 25 6 3 26 6 5 0.45 NS
BMI 5 body mass index.
Table 2. Spirometric Values of Control Group and Patients
Control Group Patients p Value
FEV1 (liter) 2.8 6 0.8 1.9 6 0.7 ,0.001 s
%pred FEV1 111 6 32 86 6 22 ,0.001 s
VC (liter) 3.9 6 0.9 2.6 6 0.8 0.0012 s
%pred VC 116 6 10 88 6 18 0.0002 s
FEV1/VC 0.80 6 0.06 0.73 6 0.11 0.12 NS
FEV1 5 forced expiratory volume in 1 s (liter/sec); %pred FEV1 5 percentage of
predicted FEV1; %pred VC 5 percentage of predicted VC; VC 5 vital capacity
(liter).
Table 3. Cardiorespiratory Exercise Measurement in Control
Group and Patients
Control
Group Patients
p
value
VO2 peak/ml/min 1537 6 647 1382 6 469 0.48 NS
VO2 peak ml/kg/min 21.7 6 7.4 20.4 6 5 0.42 NS
%pred VO2max 97 6 18 94 6 14 0.7 NS
Wmax (watts) 115 6 39 93 6 36 0.13 NS
VEmax liter/min 57 6 26 48 6 15 0.32 NS
%pred VEmax 55 6 20 68 6 14 0.07 NS
%VR 43 6 20 31 6 14 0.08 NS
VE/VO2 39 6 8 34 6 4 0.2 NS
VE/VCO2 31 6 5 30 6 2 0.61 NS
Basal HR (beats/min) 71 6 9 75 6 11 0.18 NS
HRmax (beats/min) 147 6 17 134 6 19 0.11 NS
HRmax % (% basal HR) 107 6 12 78 6 14 0.02 s
%pred HRmax 91 6 9 82 6 11 0.03 s
R 1.23 6 0.09 1.13 6 0.12 0.03 s
Vt (ml/min) 891 6 300 947 6 298 0.46 NS
HR 5 heart rate; %pred VO2max 5 percentage of predicted VO2 max; %pred VE 5
percentage of predicted VEmax; %pred HRmax 5 percentage of predicted HRmax;
R 5 respiratory gas exchange ratio (VCO2/VO2); VEmax 5 minute ventilation at peak
exercise; Vt 5 ventilatory threshold; VO2 peak 5 peak oxygen consumption; VR 5
ventilatory reserve; Wmax 5 maximal workload.
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resting peak gradient and early after peak exercise gradient
was found (Fig. 4). No significant correlation was observed
between exercise capacity (VO2max or maximal workload
[Wmax]) and the following data: prosthesis area, rest and
early after peak exercise gradients (Fig. 5), body surface, or
the body surface/prosthesis area ratio.
However, a significant correlation existed between the
prosthesis area at rest and the values of mean and early after
peak exercise gradients (respectively, y 5 71.5 2 34.03, r 5
20.80, p , 0.01; and y 5 117.9 2 54.43, r 5 20.74, p ,
0.01). Finally, when we compared subgroups of patients
with two different prosthesis sizes (19 or 21 mm), we did
not observe a difference in VO2 peak.
DISCUSSION
To our knowledge, this study was the first to compare the
exercise tolerance between a healthy control group and a
small aortic prosthesis group. The main result was a similar
exercise tolerance, expressed by VO2 peak or Wmax, with no
significant differences between the patient and control
groups. The use of a small aortic prosthesis, therefore, did
not appear to induce exercise intolerance. Moreover, the
mean and peak gradients at rest and early after peak exercise
were not correlated with VO2 peak. Although the values of
these gradients were higher than those usually observed in
medium-size aortic prostheses, this did not seem to be a
cause of exercise limitation.
Methods. All patients in our study had a body surface area
of less than 1.7 m2, for which the usual recommendation is
Figure 1. Comparison between exercise capacity of patients (n 5 14) with controls (n 5 14).
Figure 2. Plot of individual data of early after peak exercise gradients for
No. 19 and No. 21 prostheses.
Figure 3. Plot of individual data of early after peak exercise gradients for
Medtronic Hall (MH) and St. Jude Medical (SJM).
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implantation of a small aortic prosthesis (3). The evaluation
of exercise tolerance by VO2max measurement in patients
with a small aortic prosthesis was easily obtained without
adverse complication. In addition, a noninvasive hemody-
namic study by Doppler echocardiography was also possible
at rest and early after peak exercise in all patients. However,
we did not compare the Doppler echocardiographic data
with reference standard catheterization data. Indeed, in the
smaller 19- and 21-mm sizes, the difference between Dopp-
ler and catheter gradients may be more than 20 mm Hg,
particularly at high flow rates (19). In previous studies where
close agreement between catheter and Doppler data was
shown, the subgroup of small valve sizes was not well
represented (19,20). Nevertheless, from an ethical point of
view, performance of this invasive evaluation did not appear
to be sufficiently justified in our study.
Exercise tolerance. In terms of VO2 peak, we found a
preserved exercise tolerance; no statistically significant dif-
ference existed in the level of maximal exercise between the
two groups when this parameter was expressed as %predict-
ed VO2max or maximal workload. Only maximal HR was
slightly higher in the control group, probably linked to a
nonsignificantly higher maximal workload (115 6 39 vs.
93 6 36; p 5 0.13; NS). Despite a mild restrictive
Figure 4. Correlation between rest and early after peak exercise prosthesis gradients. (The correlation does not persist if we suppress the leverage point in
the upper right corner of the graph.)
Figure 5. No correlations between peak gradients (rest and early after exercise) and VO2max were observed. Open square 5 early after exercise peak gradient;
closed circle 5 rest peak gradient.
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respiratory syndrome, the patients had a normal breathing
pattern, with no differences between the two groups for
VEmax or ventilatory equivalents. The ventilatory threshold
occurred slightly sooner in the patients but was not signif-
icantly different, which suggested there was no muscular
impairment. The use of a small aortic prosthesis did not
seem to induce an exercise intolerance.
The hemodynamic performance and exercise capacity did
not differ between the patients with SJM and those with
MH. In the subgroups, with two different diameters (19 and
21 mm) and two types of prostheses, the exercise tolerance
did not significantly differ.
It would of course be helpful to compare these exercise
tolerance measurements with preoperative data, but in this
study the main etiology for which aortic valve replacement
was indicated was a predominant aortic stenosis (13/14
patients). Therefore, we did not conduct cardiorespiratory
testing before surgery because it is classically contraindicated
in this pathology.
All patients presented a preserved left ventricular systolic
function before surgery. Respiratory functional exploration
performed two years after surgery found impaired respira-
tory function with a mild restrictive syndrome, probably
associated with the thoracic surgery. The spirometric ab-
normalities we observed have already been described at the
two-month follow-up after cardiac surgery (21).
Doppler hemodynamic data and VO2max. The VO2max
was not correlated with the hemodynamic parameters (i.e.,
the transprosthetic gradients at rest and early after peak
exercise) and the functional surface of the valve. Many
previous studies have used cardiac catheterization for hemo-
dynamic valuation, but this procedure introduced additional
risks to patients, especially during exercise. The use of
noninvasive Doppler echocardiography during exercise was
an excellent means of studying the hemodynamic modifi-
cations.
Similar to the data reported by Wiseth et al. (4), the
gradients during exercise were correlated with the resting
gradients. In addition, rest and exercise prosthetic gradients
did not differ between the two valve types or between the
two sizes. This was true despite the mechanical differences,
with a bi-leaflet tilting-disk design in SJM prostheses and a
single tilting-disk design, with a less homogeneous velocity
distribution across the valve orifice, in MH prostheses (19).
The transaortic Doppler exercise measurement was per-
formed early after peak exercise, in the first minute of active
recovery. This was not really the “peak exercise,” but
hemodynamic conditions are very similar between peak and
early active recovery of a maximal exercise test (22). Indeed,
although HR and cardiac output rapidly decrease, the stroke
volume is maintained or increased due to an increment of
venous return (23).
Comparison with previous studies. Very few studies have
specifically investigated the parameters influencing exercise
capacity and exercise hemodynamics in patients after aortic
valve replacement, especially with a small-size prosthesis.
Tatineni et al. (5) showed in patients with an aortic
prosthesis that the ejection fraction and other parameters of
left ventricular function were not predictive of exercise
capacity. Only age and valvular size were independent
predictors of exercise tolerance, which might be explained
by the higher gradients in small prostheses (2). But in their
study, the exercise tolerance was evaluated by exercise
duration, and the correlation with prosthesis size was weak
(r 5 0.41; p , 0.05). Moreover, these data were not
compared with those of a control group, and during these
invasive studies the ability to complete exercise may have
been limited in the patients, which would explain the
moderate increase in gradient. Nitter-Hauge et al. (24)
showed, in 10 patients with MH of usual size (21 to
27 mm), a mean gradient of 2.9 mm Hg at rest and
increasing to 6.8 mm Hg during exercise.
Using Doppler echocardiography for a subgroup of 14
patients with MH 21 mm, Wiseth et al. (4) reported mean
and peak gradients, at rest in supine position, of, respec-
tively, 15 6 4 and 30 6 8, increased to 24 6 6 and 47 6
11 mm Hg during exercise. Aris et al. (25) reported, for 12
patients with SJM 19 mm, a mean resting gradient of 22 6
7 mm Hg, increased during supine exercise to 32 6
10 mm Hg, and for 16 patients with MH 20 mm, a mean
resting gradient of 17 6 5 mm Hg, increased to 24 6
8 mm Hg.
In another study by Tatieni et al. (5), 12 patients had
prosthesis sizes #21 mm (data extracted from figure), and
their peak exercise gradients ranged from 22 to 52 mm Hg.
For Wiseth et al. (4), the range was from 25 to 67 mm Hg,
and in our study it was from 25 to 103 mm Hg. Thus, our
data show mean gradients at rest and during exercise that
are comparable to those of Aris et al. (25) (21 6 8 vs. 22 6
7 and 33 6 14 vs. 32 6 10 mm Hg, respectively), but the
peak exercise gradients were higher in our study probably
because one patient had values near 100 mm Hg at exercise.
More recently, Kadir et al. (26) studied the hemodynamic
performance in patients with small-size SJM, using dobut-
amine echocardiography. They observed an increase in
mean transvalvular gradient from 22 6 4.9 mm Hg at rest
to 41.9 6 9 mm Hg at maximum stress (respectively, 21 6
8 mm Hg and 33 6 14 in our study).
Concerning the comparison between the exercise capacity
in patients with SJM and MH, our finding was similar to
that observed in the prospective randomized trial of Fiore et
al. (27): their study could not detect a difference in clinical
performance or dobutamine stress transesophageal Doppler
echocardiography between SJM and MH.
If we summarized these data, we may conclude that our
method of measuring the transvalvular gradient in sitting
position, at rest, and immediately after exercise was reliable
and comparable to other methods (dobutamine stress).
Conclusions. In patients without preliminary ventricular
dysfunction who presented a small body surface (,1.7 m2),
the implantation of small aortic prostheses did not provoke
an alteration in exercise tolerance compared with controls.
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This demonstrates that the high values of gradient observed
in small-sized prostheses at rest and during exercise, in
comparison with those of medium sizes, are not correlated
with exercise tolerance. Thus, the residual outflow obstruc-
tion seems to have no functional consequence.
Finally, in cases of small aortic root, the use of SJM or
MH valve prostheses with diameters #21 mm did not
appear to be a factor of execise intolerance. This was so
despite higher rest and exercise gradients than those ob-
served in “medium”-sized prostheses.
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